![]() PDL1/ Rat PDL1 ELISA Kit |
|||
ELA-E0513r | Lifescience Market | 96 Tests | EUR 886.00 |
![]() pEGFP- PDL1 |
|||
PVT10283 | Lifescience Market | 2 ug | EUR 301.00 |
![]() h CD274 (PDL1) (6His) inducible lentiviral particles |
|||
LVP1077 | GenTarget | 1x107 IFU/ml x 200ul | EUR 451.00 |
Description: Pre-made over-expression lentivirus for expressing C-terminal His-Taggedhuman target: CD274 (6His) (human CD274 molecule), [alternative names: B7-H; B7H1; PD-L1; PDCD1L1; PDCD1LG1; PDL1]. The sub-cloned codon sequence is identical (100% match) to CDS region in NCBI ID: NM_014143.3. It contains a RFP-Blasticidin dual selection marker. |
![]() Programmed Cell Death Protein 1 Ligand 1 (PDL1) Antibody (Biotin) |
|||
20-abx274655 | Abbexa |
|
|
|
![]() Programmed Cell Death Protein 1 Ligand 1 (PDL1) Monoclonal Antibody (Human) |
|||
4-MAA788Hu21 | Cloud-Clone |
|
|
|
|||
Description: A Mouse monoclonal antibody against Human Programmed Cell Death Protein 1 Ligand 1 (PDL1) |
![]() Programmed Cell Death Protein 1 Ligand 1 (PDL1) Monoclonal Antibody (Rat) |
|||
4-MAA788Ra21 | Cloud-Clone |
|
|
|
|||
Description: A Mouse monoclonal antibody against Rat Programmed Cell Death Protein 1 Ligand 1 (PDL1) |
![]() h CD274 (PDL1) (6His, GFP-Puro) inducible lentiviral particles |
|||
LVP1077-GP | GenTarget | 1x107 IFU/ml x 200ul | EUR 451.00 |
Description: Pre-made over-expression lentivirus for expressing C-terminal His-Taggedhuman target: CD274 (6His) (human CD274 molecule), [alternative names: B7-H; B7H1; PD-L1; PDCD1L1; PDCD1LG1; PDL1]. The sub-cloned codon sequence is identical (100% match) to CDS region in NCBI ID: NM_014143.3. It contains a GFP-Puromycin dual selection marker. |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC552746-100 | Biotium | 100uL | EUR 233.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF555 conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC552746-500 | Biotium | 500uL | EUR 545.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF555 conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC612746-100 | Biotium | 100uL | EUR 233.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF660R conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC612746-500 | Biotium | 500uL | EUR 545.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF660R conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC402746-100 | Biotium | 100uL | EUR 233.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF640R conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC402746-500 | Biotium | 500uL | EUR 545.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF640R conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC472746-100 | Biotium | 100uL | EUR 233.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF647 conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC472746-500 | Biotium | 500uL | EUR 545.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF647 conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC052746-100 | Biotium | 100uL | EUR 233.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF405M conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC052746-500 | Biotium | 500uL | EUR 545.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF405M conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC042746-100 | Biotium | 100uL | EUR 233.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF405S conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC042746-500 | Biotium | 500uL | EUR 545.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF405S conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC432746-100 | Biotium | 100uL | EUR 233.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF543 conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC432746-500 | Biotium | 500uL | EUR 545.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF543 conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNUB2746-100 | Biotium | 100uL | EUR 264.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), Concentration: 0.2mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNUB2746-500 | Biotium | 500uL | EUR 513.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), Concentration: 0.2mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNUM2746-50 | Biotium | 50uL | EUR 405.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), 1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC682746-100 | Biotium | 100uL | EUR 233.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF568 conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC682746-500 | Biotium | 500uL | EUR 545.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF568 conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC882746-100 | Biotium | 100uL | EUR 233.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF488A conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC882746-500 | Biotium | 500uL | EUR 545.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF488A conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC942746-100 | Biotium | 100uL | EUR 233.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF594 conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC942746-500 | Biotium | 500uL | EUR 545.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF594 conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNCB2746-100 | Biotium | 100uL | EUR 233.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), Biotin conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNCB2746-500 | Biotium | 500uL | EUR 545.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), Biotin conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC702746-100 | Biotium | 100uL | EUR 233.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF770 conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC702746-500 | Biotium | 500uL | EUR 545.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF770 conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC802746-100 | Biotium | 100uL | EUR 233.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF680 conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC802746-500 | Biotium | 500uL | EUR 545.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF680 conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNCH2746-100 | Biotium | 100uL | EUR 233.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNCH2746-500 | Biotium | 500uL | EUR 545.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNCP2746-250 | Biotium | 250uL | EUR 394.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), PerCP conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNCA2746-250 | Biotium | 250uL | EUR 394.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), APC conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNCAP2746-100 | Biotium | 100uL | EUR 233.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNCAP2746-500 | Biotium | 500uL | EUR 545.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC812746-100 | Biotium | 100uL | EUR 233.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF680R conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNC812746-500 | Biotium | 500uL | EUR 545.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF680R conjugate, Concentration: 0.1mg/mL |
![]() PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
BNCR2746-250 | Biotium | 250uL | EUR 394.00 |
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), RPE conjugate, Concentration: 0.1mg/mL |
![]() Programmed Cell Death Protein 1 Ligand 1 (PDL1) Monoclonal Antibody (Human), APC |
|||
4-MAA788Hu21-APC | Cloud-Clone |
|
|
|
|||
Description: A Mouse monoclonal antibody against Human Programmed Cell Death Protein 1 Ligand 1 (PDL1). This antibody is labeled with APC. |
![]() Programmed Cell Death Protein 1 Ligand 1 (PDL1) Monoclonal Antibody (Human), Biotinylated |
|||
4-MAA788Hu21-Biotin | Cloud-Clone |
|
|
|
|||
Description: A Mouse monoclonal antibody against Human Programmed Cell Death Protein 1 Ligand 1 (PDL1). This antibody is labeled with Biotin. |
![]() Programmed Cell Death Protein 1 Ligand 1 (PDL1) Monoclonal Antibody (Human), Cy3 |
|||
4-MAA788Hu21-Cy3 | Cloud-Clone |
|
|
|
|||
Description: A Mouse monoclonal antibody against Human Programmed Cell Death Protein 1 Ligand 1 (PDL1). This antibody is labeled with Cy3. |
![]() Programmed Cell Death Protein 1 Ligand 1 (PDL1) Monoclonal Antibody (Human), FITC |
|||
4-MAA788Hu21-FITC | Cloud-Clone |
|
|
|
|||
Description: A Mouse monoclonal antibody against Human Programmed Cell Death Protein 1 Ligand 1 (PDL1). This antibody is labeled with FITC. |
![]() Programmed Cell Death Protein 1 Ligand 1 (PDL1) Monoclonal Antibody (Human), HRP |
|||
4-MAA788Hu21-HRP | Cloud-Clone |
|
|
|
|||
Description: A Mouse monoclonal antibody against Human Programmed Cell Death Protein 1 Ligand 1 (PDL1). This antibody is labeled with HRP. |
![]() Programmed Cell Death Protein 1 Ligand 1 (PDL1) Monoclonal Antibody (Human), PE |
|||
4-MAA788Hu21-PE | Cloud-Clone |
|
|
|
|||
Description: A Mouse monoclonal antibody against Human Programmed Cell Death Protein 1 Ligand 1 (PDL1). This antibody is labeled with PE. |
![]() Programmed Cell Death Protein 1 Ligand 1 (PDL1) Monoclonal Antibody (Rat), APC |
|||
4-MAA788Ra21-APC | Cloud-Clone |
|
|
|
|||
Description: A Mouse monoclonal antibody against Rat Programmed Cell Death Protein 1 Ligand 1 (PDL1). This antibody is labeled with APC. |
![]() Programmed Cell Death Protein 1 Ligand 1 (PDL1) Monoclonal Antibody (Rat), Biotinylated |
|||
4-MAA788Ra21-Biotin | Cloud-Clone |
|
|
|
|||
Description: A Mouse monoclonal antibody against Rat Programmed Cell Death Protein 1 Ligand 1 (PDL1). This antibody is labeled with Biotin. |
![]() Programmed Cell Death Protein 1 Ligand 1 (PDL1) Monoclonal Antibody (Rat), Cy3 |
|||
4-MAA788Ra21-Cy3 | Cloud-Clone |
|
|
|
|||
Description: A Mouse monoclonal antibody against Rat Programmed Cell Death Protein 1 Ligand 1 (PDL1). This antibody is labeled with Cy3. |
![]() Programmed Cell Death Protein 1 Ligand 1 (PDL1) Monoclonal Antibody (Rat), FITC |
|||
4-MAA788Ra21-FITC | Cloud-Clone |
|
|
|
|||
Description: A Mouse monoclonal antibody against Rat Programmed Cell Death Protein 1 Ligand 1 (PDL1). This antibody is labeled with FITC. |